Viking Therapeutics Inc (NASDAQ: VKTX) open the trading on Thursday, with great promise as it jumped 8.38% to $38.17, before settling in for the price of $35.22 at the close. Taking a more long-term approach, VKTX posted a 52-week range of $18.92-$79.10.
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was -23.00%. Meanwhile, its Annual Earning per share during the time was -23.00%. Nevertheless, stock’s Earnings Per Share (EPS) this year is -168.51%. This publicly-traded company’s shares outstanding now amounts to $112.45 million, simultaneously with a float of $109.67 million. The organization now has a market capitalization sitting at $4.31 billion. At the time of writing, stock’s 50-day Moving Average stood at $29.07, while the 200-day Moving Average is $29.24.
Viking Therapeutics Inc (VKTX) Ownership Facts and Figures
Sometimes it helps to make our mind if we keep our tabs on how bigger investors are working with the stock of the Biotechnology industry. Viking Therapeutics Inc’s current insider ownership accounts for 2.98%, in contrast to 67.37% institutional ownership. According to the most recent insider trade that took place on Oct 28 ’25, this organization’s Chief Operating Officer sold 6,185 shares at the rate of 35.00, making the entire transaction reach 216,492 in total value, affecting insider ownership by 382,467. Preceding that transaction, on Oct 27 ’25, Company’s Director sold 60,000 for 35.57, making the whole transaction’s value amount to 2,134,278. This particular insider is now the holder of 30,000 in total.
Viking Therapeutics Inc (VKTX) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.95 per share during the current fiscal year.
Viking Therapeutics Inc’s EPS decrease for this current 12-month fiscal period is -168.51% and is forecasted to reach -3.70 in the upcoming year.
Viking Therapeutics Inc (NASDAQ: VKTX) Trading Performance Indicators
Let’s observe the current performance indicators for Viking Therapeutics Inc (VKTX). It’s Quick Ratio in the last reported quarter now stands at 28.34.
In the same vein, VKTX’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -2.12, a figure that is expected to reach -0.89 in the next quarter, and analysts are predicting that it will be -3.70 at the market close of one year from today.
Technical Analysis of Viking Therapeutics Inc (VKTX)
[Viking Therapeutics Inc, VKTX] recent stats showed that its last 5-days Average volume was poorer than the volume it posted in the year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 76.85% While, its Average True Range was 71.33.
Raw Stochastic average of Viking Therapeutics Inc (VKTX) in the period of the previous 100 days is set at 78.93%, which indicates a major fall in contrast to 83.94% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 2.05 that was higher than 1.75 volatility it exhibited in the past 100-days period.
